Abstract

The biological function of short non-coding RNAs known as micro RNAs (miRNAs) is unravelling to uncover a complex arrangement within every cell whereby they modulate most cellular responses. There has been much investigation as to the influence of miRNA on cell signalling processes and their cellular effects. Moreover, recently miRNA have been implicated in both physiological responses, as well as having critical roles in a variety of diseased states. The effects of these unique biochemical regulators are often subtle, but decisive with regards to a cell’s pathophysiology and disease. Researchers have investigated both the regulation of signalling pathways by miRNA, but also the regulation of miRNA generation processes by signalling steps themselves. There exists an interesting interrelationship whereby miRNA can reinforce a cell’s signalling effects. Thus miRNA have a role in normal cell physiological functioning. Aberrant miRNA generation would therefore lead to unruly signalling activity through which disease often results from such dysregulation. We will review the roles for miRNA here with emphasis on their function in human leukemia. Better understanding of these mechanisms that underlie pathologically-relevant signalling alterations that create cancer or are involved in cancer chemotherapy-resistance, will lead to better targeting and treatments for not only leukemia, but all relevant cancers.

Highlights

  • MicroRNA are 20-24 short non-coding RNA molecules that bind and repress their target mRNA

  • One study aimed to identify micro RNAs (miRNAs) expression between Chronic Lymphocytic Leukemia (CLL) patients and control cells, finding changes in expression levels of several miRNA including miR-123, miR-10b, miR-181b, miR-192, miR-220, miR-155 and miR-213.This study suggested miRNA can be used to distinguish between both IgHv mutations and ZAP70 levels [42]

  • As in AML, miR-155 is overexpressed in CLL [42], and is highly expressed in patients who respond poorly to treatment or are unresponsive to fludarabine chemotherapy[47].miR-155 can be regulated by several proteins including the Myb and Smad4 [48,49]. miR-155 can target the tumour suppressor PU.1 which in addition to being a key tumour suppressor in AML is important in CLL. miR-155 can target the phosphatase SHIP1, which reduces breakpoint cluster region (BCR) sensitivity

Read more

Summary

Introduction

MicroRNA (miRNA) are 20-24 short non-coding RNA molecules that bind and repress their target mRNA. Studies have shown miRNA can play an important role in most cellular processes including migration, differentiation, apoptosis and proliferation [2]. One study used a genome-wide miRNA expression profile between acute lymphocytic leukemia (ALL) and AML, and identified 27 different miRNAs that displayed significant differential expression between these two disease subtypes.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.